SCHEMBL17653252

SCHEMBL17653252

CCc1nc(N(CCC(C)C)C(=O)OCc2ccccc2)nc2ccc(Br)cc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AAK1 Q2M2I8 5/20 0.41
MMP13 P45452 2/20 0.36
MMP2 P08253 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
ALDH1A1 P00352 1/20 0.36
MEN1 O00255 1/20 0.35
HSP90AA1 P07900 1/20 0.35
KMT2A Q03164 1/20 0.35
LMNA P02545 3/20 0.34
USP2 O75604 1/20 0.34
PIK3CD O00329 1/20 0.34
PIK3R1 P27986 1/20 0.34
HTT P42858 1/20 0.34
HIF1A Q16665 1/20 0.34
ATM Q13315 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
DPP4 P27487 1/20 0.34
POLB P06746 1/20 0.34
MCL1 Q07820 1/20 0.33
GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17653094 0.87 AAK1 (0.38) AAK1MMP13MMP2SMN1; SMN2ALDH1A1
SCHEMBL17653212 0.86 AAK1 (0.53) AAK1MMP13MMP2
SCHEMBL17653121 0.85 CYP3A4 (0.34) AAK1MMP13MMP2SMN1; SMN2KMT2A
SCHEMBL17653141 0.84 AAK1 (0.38) AAK1MEN1HSP90AA1KMT2AHTT
SCHEMBL17653187 0.83 AAK1 (0.46) AAK1MEN1HSP90AA1KMT2AHTT
SCHEMBL17653133 0.80 AAK1 (0.42) AAK1SMN1; SMN2ALDH1A1
SCHEMBL17653108 0.80 AAK1 (0.49) AAK1ALDH1A1LMNAUSP2
SCHEMBL17653349 0.80 AAK1 (0.45) AAK1SMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL17653344 0.79 AAK1 (0.36) AAK1SMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL17653172 0.78 AAK1 (0.39) AAK1SMN1; SMN2ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3200797-A1 QUINAZOLINE-BASED KINASE INHIBITORS Bristol-Myers Squibb Company (US) 2017-08-09 EP disclosed
WO-2016053794-A1 QUINAZOLINE-BASED KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2016-04-07 WO disclosed